A live vaccine to Staphylococcus aureus infection

References

• MoscosoM, GarciaP, CabralMP, et al.A D-Alanine auxotrophic live vaccine is effective against Lethal infection caused by Staphylococcus aureus. Virulence.2018; doi:10.1080/21505594.2017.1417723
   PubMed Web of Science ®Google Scholar
• WisplinghoffH, BischoffT, TallentSM, et al.Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis.2004;39:309–17. doi:10.1086/421946
   PubMed Web of Science ®Google Scholar
• WertheimHF, VosMC, OttA, et al.Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet.2004;364:703–5. doi:10.1016/S0140-6736(04)16897-9
   PubMed Web of Science ®Google Scholar
• GorwitzRJ, Kruszon-MoranD, McAllisterSK, et al.Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis.2008;197:1226–34. doi:10.1086/533494
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antimicrobial Resistance Global Report on Surveillance. 2014.
   Google Scholar
• CDC. Antibiotic Resistance Threats in the United States, 2013. 2013.
   Google Scholar
• UematsuH, YamashitaK, KunisawaS, et al.Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals. PLoS One.2017;12:e0179767. doi:10.1371/journal.pone.0179767
   PubMed Web of Science ®Google Scholar
• LeeBY, SinghA, DavidMZ, et al.The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect.2013;19:528–36. doi:10.1111/j.1469-0691.2012.03914.x
   PubMed Web of Science ®Google Scholar
• KlevensRM, MorrisonMA, NadleJ, et al.Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA.2007;298:1763–71. doi:10.1001/jama.298.15.1763
   PubMed Web of Science ®Google Scholar
• DaumRS, SpellbergB. Progress toward a Staphylococcus aureus vaccine. Clin Infect Dis.2012;54:560–7. doi:10.1093/cid/cir828
   PubMed Web of Science ®Google Scholar
• AndersonAS, MillerAA, DonaldRG, et al.Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum Vaccin Immunother.2012;8:1585–94. doi:10.4161/hv.21872
   PubMed Web of Science ®Google Scholar
• FattomAI, SarwarJ, OrtizA, et al.A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect Immun.1996;64:1659–65.
   PubMed Web of Science ®Google Scholar
• ShinefieldH, BlackS, FattomA, et al.Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med.2002;346:491–6. doi:10.1056/NEJMoa011297
   PubMed Web of Science ®Google Scholar
• FattomAI, HorwithG, FullerS, et al.Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine.2004;22:880–7. doi:10.1016/j.vaccine.2003.11.034
   PubMed Web of Science ®Google Scholar
• KuklinNA, ClarkDJ, SecoreS, et al.A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun.2006;74:2215–23. doi:10.1128/IAI.74.4.2215-2223.2006
   PubMed Web of Science ®Google Scholar
• FowlerVG, AllenKB, MoreiraED, et al.Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA.2013;309:1368–78. doi:10.1001/jama.2013.3010
   PubMed Web of Science ®Google Scholar
• WarrenHS, TompkinsRG, MoldawerLL, et al.Mice are not men. Proc Natl Acad Sci U S A.2015;112:E345. doi:10.1073/pnas.1414857111
   PubMed Web of Science ®Google Scholar
• KimHK, MissiakasD, SchneewindO. Mouse models for infectious diseases caused by Staphylococcus aureus. J Immunol Methods.2014;410:88–99. doi:10.1016/j.jim.2014.04.007
   PubMed Web of Science ®Google Scholar
• Salgado-PabonW, SchlievertPM. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol.2014;12:585–91. doi:10.1038/nrmicro3308
   PubMed Web of Science ®Google Scholar
• ProctorRA. Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis.2012;54:1179–86. doi:10.1093/cid/cis033
   PubMed Web of Science ®Google Scholar
• AlonzoF, 3rd, TorresVJ. Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. PLoS Pathog.2013;9:e1003143. doi:10.1371/journal.ppat.1003143
   PubMed Web of Science ®Google Scholar
• ParkerD, PrinceA. Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol.2012;34:281–97. doi:10.1007/s00281-011-0291-7
   PubMed Web of Science ®Google Scholar
• KimHK, FalugiF, ThomerL, et al.Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs. MBio.2015;6:e02369–14. doi:10.1128/mBio.02369-14
   PubMed Web of Science ®Google Scholar
• RauchS, GoughP, KimHK, et al.Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infect Immun.2014;82:4889–98. doi:10.1128/IAI.02328-14
   PubMed Web of Science ®Google Scholar
• AndersonAS, ScullyIL, TimofeyevaY, et al.Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. J Infect Dis.2012;205:1688–96. doi:10.1093/infdis/jis272
   PubMed Web of Science ®Google Scholar
• McAdowM, KimHK, DedentAC, et al.Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog.2011;7:e1002307. doi:10.1371/journal.ppat.1002307
   PubMed Web of Science ®Google Scholar
• VollmerW, BlanotD, de PedroMA. Peptidoglycan structure and architecture. FEMS Microbiol Rev.2008;32:149–67. doi:10.1111/j.1574-6976.2007.00094.x
   PubMed Web of Science ®Google Scholar